iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)’s stock price traded up 5.4% on Monday . The company traded as high as $135.06 and last traded at $134.71. 4,987,996 shares were traded during trading, an increase of 43% from the average session volume of 3,499,835 shares. The stock had previously closed at $127.79.

Separately, ValuEngine downgraded shares of iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a report on Thursday, July 2nd.

The stock’s 50 day moving average is $133.34 and its two-hundred day moving average is $127.13.

Large investors have recently bought and sold shares of the company. Cullen Frost Bankers Inc. acquired a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter valued at approximately $41,000. Watson Rebecca purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 2nd quarter worth $43,000. Hoover Financial Advisors Inc. acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the 2nd quarter valued at about $46,000. First National Bank of South Miami grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 56.4% in the first quarter. First National Bank of South Miami now owns 352 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 127 shares during the period. Finally, CNB Bank purchased a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth about $71,000. 82.54% of the stock is currently owned by hedge funds and other institutional investors.

About iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Yield Curve

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.